References
- LinLL-KShihY-FTsaiC-BEpidemiologic study of ocular refraction among schoolchildren in Taiwan in 1995Optom Vis Sci199976527528110375241
- JungSKLeeJHKakizakiHJeeDPrevalence of myopia and its association with body stature and educational level in 19-year-old male conscripts in Seoul, South KoreaInvest Ophthalmol Vis Sci20125395579558322836765
- SunJZhouJZhaoPHigh prevalence of myopia and high myopia in 5060 Chinese university students in ShanghaiInvest Ophthalmol Vis Sci201253127504750923060137
- KohVYangASawSMDifferences in prevalence of refractive errors in young Asian males in Singapore between 1996–1997 and 2009–2010Ophthalmic Epidemiol201421424725524990474
- HoldenBSankaridurgPSmithEAllerTJongMHeMMyopia, an underrated global challenge to vision: where the current data takes us on myopia controlEye (Lond)201428214214624357836
- SherwinJCMackeyDAUpdate on the epidemiology and genetics of myopic refractive errorExpert Rev Ophthalmol2013816387
- MorganIGOhno-MatsuiKSawSMMyopiaLancet201237998271739174822559900
- LeoSWYoungTLAn evidence-based update on myopia and interventions to retard its progressionJ AAPOS201115218118921596297
- JonesDLuensmannDThe prevalence and impact of high myopiaEye Contact Lens201238318819622495679
- WallineJJGreinerKLMcVeyMEJones-JordanLAMultifocal contact lens myopia controlOptom Vis Sci201390111207121424061152
- CooperJSchulmanEJamalNCurrent status on the development and treatment of myopiaOptometry201283517919923249121
- GwiazdaJTreatment options for myopiaOptom Vis Sci200986662462819390466
- ChuaWHBalakrishnanVChanYHAtropine for the treatment of childhood myopiaOphthalmology2006113122285229116996612
- ChiaAChuaWHCheungYBAtropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (atropine for the treatment of myopia 2)Ophthalmology2012119234735421963266
- CooperJEisenbergNSchulmanEWangFMMaximum atropine dose without clinical signs or symptomsOptom Vis Sci201390121467147224076540
- ChiaALuQSTanDFive-year clinical trial on atropine for the treatment of myopia 2 myopia control with atropine 0.01% eyedropsOphthalmology2016123239139926271839
- BartlettJDNiemannKHoudeBAllredTEdmondsonMJCrockettRSA tolerability study of pirenzepine ophthalmic gel in myopic childrenJ Ocul Pharmacol Ther200319327127912828845
- SiatkowskiRMCotterSMillerJMUS Pirenzepine Study GroupSafety and efficacy of 2% pirenzepine ophthalmic gel in children with myopia: a 1-year, multicenter, double-masked, placebo-controlled parallel studyArch Ophthalmol2004122111667167415534128
- SiatkowskiRMCotterSACrockettRSU.S. Pirenzepine Study GroupTwo-year multicenter, randomized, double-masked, placebo-controlled, parallel safety and efficacy study of 2% pirenzepine ophthalmic gel in children with myopiaJ AAPOS200812433233918359651
- TanDTLamDSChuaWHShu-PingDFCrockettRSAsian Pirenzepine Study GroupOne-year multicenter, double-masked, placebo-controlled, parallel safety and efficacy study of 2% pirenzepine ophthalmic gel in children with myopiaOphthalmology20051121849115629825
- WhiteCJByrneMEMolecularly imprinted therapeutic contact lensesExpert Opin Drug Deliv20107676520408742
- SedlácekJPossibility of the application of ophthalmic drugs with the use of gel contact lensesCesk Oftalmol19652165095125849837
- WichterleOLimDinventorsMethod for producing shaped articles from three-dimensional hydrophilic polymersUnited States patent US2976576 A1961328
- NordstromBLFriedmanDSMozaffariEQuigleyHAWalkerAMPersistence and adherence with topical glaucoma therapyAm J Ophthalmol2005140459860616226511
- WallineJJJonesLASinnottLRandomized trial of the effect of contact lens wear on self-perception in childrenOptom Vis Sci200986322223219214129
- RahMJWallineJJJones-JordanLAVision specific quality of life of pediatric contact lens wearersOptom Vis Sci201087856056620562669
- HuiABooneAJonesLUptake and release of ciprofloxacin-HCl from conventional and silicone hydrogel contact lens materialsEye Contact Lens200834526618779666
- PhanCMSubbaramanLNJonesLIn vitro uptake and release of natamycin from conventional and silicone hydrogel contact lens materialsEye Contact Lens201339216216823392304
- KarlgardCJonesLMoresoliCUptake and release of Acular from silicone-hydrogel and conventional hydrogel contact lens materialsOptom Vis Sci20007712s179
- BooneAHuiAJonesLUptake and release of dexamethasone phosphate from silicone hydrogel and group I, II, and IV hydrogel contact lensesEye Contact Lens200935526019657281
- SoluriAHuiAJonesLDelivery of ketotifen fumarate by commercial contact lens materialsOptom Vis Sci20128981140114922773177
- KarlgardCJonesLMoresoliCUptake and release of ciloxan from silicone-hydrogel and conventional hydrogel contact lens materialsInvest Ophthalmol Vis Sci2001424s592
- Alvarez-LorenzoCHirataniHGómez-AmozaJLMartínez-PachecoRSoutoCConcheiroASoft contact lenses capable of sustained delivery of timololJ Pharm Sci20029110218212226845
- ByrneMEParkKPeppasNAMolecular imprinting within hydrogelsAdv Drug Deliv Rev200254114911755710
- HirataniHAlvarez-LorenzoCTimolol uptake and release by imprinted soft contact lenses made of N,N-diethylacrylamide and methacrylic acidJ Control Release200283222312363448
- KarlgardCCWongNSJonesLWMoresoliCIn vitro uptake and release studies of ocular pharmaceutical agents by silicon-containing and p-HEMA hydrogel contact lens materialsInt J Pharm20032571–214115112711169
- HirataniHMizutaniYAlvarez-LorenzoCControlling drug release from imprinted hydrogels by modifying the characteristics of the imprinted cavitiesMacromol Biosci20055872816082622
- PruittJBaumanEThe development of dailies Total 1 water gradient contact lensesOptometric Management20134044
- HuiAWillcoxMJonesLIn vitro and in vivo evaluation of novel ciprofloxacin-releasing silicone hydrogel contact lensesInvest Ophthalmol Vis Sci20145584896490425028363
- PengCCBen-ShlomoAMacKayEOPlummerCEChauhanADrug delivery by contact lens in spontaneously glaucomatous dogsCurr Eye Res201237320421122335807
- DanionAArsenaultIVermettePAntibacterial activity of contact lenses bearing surface-immobilized layers of intact liposomes loaded with levofloxacinJ Pharm Sci20079692350236317541976
- LasowskiFSheardownHAtropine and roscovitine release from model silicone hydrogelsOptom Vis Sci201693440441126779867
- ChiaAChuaWHWenLFongAGoonYYTanDAtropine for the treatment of childhood myopia: changes after stopping atropine 0.01%, 0.1% and 0.5%Am J Ophthalmol20141572451457.e124315293
- MorganPBEfronNThe oxygen performance of contemporary hydrogel contact lensesCont Lens Anterior Eye19982113616303369